|

Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial

RECRUITINGSponsored by Cairo University
Actively Recruiting
SponsorCairo University
Started2025-06-22
Est. completion2025-10-30
Eligibility
Age20 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07022704

Summary

Researchers aim to evaluate the impact of doxapram administration on diaphragmatic excursion in chronic obstructive pulmonary disease (COPD) patients undergoing spontaneous breathing trial

Eligibility

Age: 20 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with moderate to severe chronic obstructive pulmonary disease undergoing spontaneous breathing trial

Exclusion Criteria:

* Refusal Allergy to doxapram neuromuscular disorders inability to evaluate the diaphragm

Conditions3

COPDMechanical VentilationWeaning From Mechanical Ventilation

Interventions1

Doxapram

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.